1-8 of 8
Donna L. Senger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A014: The novel anti-inflammatory agent GML (GM1-targeted linoleate-containing TLR2 ligand) inhibits sarcoma metastasis to the lung

Liane Babes, Lauren A. Wierenga, Ngoc-Ha Dan, Xueqing Lun, Kimberly-Ann R. Goring, Stephen M. Robbins, Donna L. Senger
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): A014.
https://doi.org/10.1158/1557-3265.SARCOMAS22-A014
Published: 15 September 2022
View article titled, Abstract A014: The novel anti-inflammatory agent GML (GM1-targeted linoleate-containing TLR2 ligand) inhibits sarcoma metastasis to the lung
Journal Articles

Abstract A006: Defining the microenvironment of alveolar soft part sarcoma & it’s role in therapeutic outcomes

Alexis M. Philippot, Ngoc Ha Dang, Shyam V. Menon, Jennifer Bourdage, Xueqing Lun, Bo Young Ahn, Stephen M. Robbins, Donna L. Senger
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): A006.
https://doi.org/10.1158/1557-3265.SARCOMAS22-A006
Published: 15 September 2022
View article titled, Abstract A006: Defining the microenvironment of alveolar soft part sarcoma & it’s role in therapeutic outcomes
Journal Articles

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

Xueqing Lun, J. Connor Wells, Natalie Grinshtein, Jennifer C. King, Xiaoguang Hao, Ngoc-Ha Dang, Xiuling Wang, Ahmed Aman, David Uehling, Alessandro Datti, Jeffrey L. Wrana, Jacob C. Easaw, Artee Luchman, Samuel Weiss, J. Gregory Cairncross, David R. Kaplan, Stephen M. Robbins, Donna L. Senger
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (15): 3860–3875.
https://doi.org/10.1158/1078-0432.CCR-15-1798
Published: 31 July 2016
View article titled, Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
Open the PDF for Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Novel MSH6 Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation

Stephanie A. Nguyen, Owen D.M. Stechishin, H. Artee Luchman, Xueqing Q. Lun, Donna L. Senger, Stephen M. Robbins, J. Gregory Cairncross, Samuel Weiss
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4894–4903.
https://doi.org/10.1158/1078-0432.CCR-13-1856
Published: 14 September 2014
View article titled, Novel <em>MSH6</em> Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of <em>MGMT</em> Promoter Methylation
Open the PDF for Novel <em>MSH6</em> Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of <em>MGMT</em> Promoter Methylation in another window
Includes: Supplementary data
Journal Articles

Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide

Xue Qing Lun, Ji-Hyun Jang, Nan Tang, Helen Deng, Renee Head, John C. Bell, David F. Stojdl, Catherine L. Nutt, Donna L. Senger, Peter A. Forsyth, J. Andrea McCart
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2777–2788.
https://doi.org/10.1158/1078-0432.CCR-08-2342
Published: 15 April 2009
View article titled, Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
Open the PDF for Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide in another window
Journal Articles

Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors

Yushui Wu, Xueqing Lun, Hongyuan Zhou, Limei Wang, Beichen Sun, John C. Bell, John W. Barrett, Grant McFadden, Jaclyn A. Biegel, Donna L. Senger, Peter A. Forsyth
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (4): 1218–1227.
https://doi.org/10.1158/1078-0432.CCR-07-1330
Published: 15 February 2008
View article titled, Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors
Open the PDF for Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals: Racine and Nonhuman Primates

Wen Qing Yang, Xueqing Lun, Cheryl Ann Palmer, M. Elizabeth Wilcox, Huong Muzik, Zhong Qiao Shi, Richard Dyck, Matt Coffey, Brad Thompson, Mark Hamilton, Sandra G. Nishikawa, Penny M. A. Brasher, Kevin Fonseca, David George, N. Berry Rewcastle, Randal N. Johnston, Doug Stewart, Patrick W. K. Lee, Donna L. Senger, Peter A. Forsyth
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8561–8576.
https://doi.org/10.1158/1078-0432.CCR-04-0940
Published: 28 December 2004
View article titled, Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals: <subtitle>Racine and Nonhuman Primates</subtitle>
Open the PDF for Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals: <subtitle>Racine and Nonhuman Primates</subtitle> in another window
Journal Articles

Altered Subcellular Localization and Low Frequency of Mutations of ING1 in Human Brain Tumors

Diego Vieyra, Donna L. Senger, Tatsuya Toyam, Huong Muzik, Penny M. A. Brasher, Randal N. Johnston, Karl Riabowol, Peter A. Forsyth
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5952–5961.
Published: 15 December 2003
View article titled, Altered Subcellular Localization and Low Frequency of Mutations of ING1 in Human Brain Tumors
Open the PDF for Altered Subcellular Localization and Low Frequency of Mutations of ING1 in Human Brain Tumors in another window